Screening HIV Patients at Risk for NAFLD Using MRI-PDFF and Transient Elastography: A European Multicenter Prospective Study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Screening HIV Patients at Risk for NAFLD Using MRI-PDFF and Transient Elastography: A European Multicenter Prospective Study
Authors
Keywords
Fibrosis, HIV, NAFLD, Risk Factors, Steatosis
Journal
Clinical Gastroenterology and Hepatology
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-04-15
DOI
10.1016/j.cgh.2022.03.048
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update
- (2021) Annalisa Berzigotti et al. JOURNAL OF HEPATOLOGY
- Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of Nonalcoholic Fatty Liver Disease
- (2020) James M. Paik et al. HEPATOLOGY
- Prevalence, predictors and severity of lean non-alcoholic fatty liver disease in HIV-infected patients
- (2020) Adriana Cervo et al. CLINICAL INFECTIOUS DISEASES
- Prevalence and Risk Factors of Moderate to Severe Hepatic Steatosis in HIV Infection: The Copenhagen Co-Morbidity Liver Study
- (2020) Ditte Marie Kirkegaard-Klitbo et al. JOURNAL OF INFECTIOUS DISEASES
- Expert Panel Review on Non-Alcoholic Fatty Liver Disease in Persons with HIV
- (2020) Jordan E. Lake et al. Clinical Gastroenterology and Hepatology
- Optimal Threshold of Controlled Attenuation Parameter for Detection of HIV-Associated NAFLD With Magnetic Resonance Imaging as the Reference Standard
- (2020) Veeral H Ajmera et al. CLINICAL INFECTIOUS DISEASES
- Diagnostic accuracy of noninvasive markers of steatosis, NASH and liver fibrosis in HIV-monoinfected individuals at-risk of non-alcoholic fatty liver disease (NAFLD)
- (2018) Maud Lemoine et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis
- (2017) Thomas Pembroke et al. JOURNAL OF HEPATOLOGY
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients
- (2016) Élise Vuille-Lessard et al. AIDS
- Prevalence and predictors of liver steatosis and fibrosis in unselected patients with HIV mono-infection
- (2016) Rosa Lombardi et al. DIGESTIVE AND LIVER DISEASE
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
- (2015) Siddharth Singh et al. Clinical Gastroenterology and Hepatology
- Risk Factors for Fatty Liver in the Multicenter AIDS Cohort Study
- (2014) Jennifer C Price et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Nonalcoholic Fatty Liver Disease: MR Imaging of Liver Proton Density Fat Fraction to Assess Hepatic Steatosis
- (2013) An Tang et al. RADIOLOGY
- Determination of reliability criteria for liver stiffness evaluation by transient elastography
- (2012) Jérôme Boursier et al. HEPATOLOGY
- The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease
- (2010) Yaron Rotman et al. HEPATOLOGY
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- Nonalcoholic Fatty Liver Disease in HIV‐Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors
- (2008) Giovanni Guaraldi et al. CLINICAL INFECTIOUS DISEASES
- Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial
- (2008) C. Duvivier et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started